Expression of Toll-like receptors in thymus of myasthenia gravis patients

Chinese Journal of Medical Genetics

Volumn 25, Issue 3, 2008, Pages 311-314

  Gao, Ke ^a   Wang, Ying Cheng ^a   Ma, Xiao Hong ^a   Li, Tao ^a   Wu, Zhu ^a   Liu, Lun Xu ^a   Che, Guo Wei ^a   Kou, Ying Li ^a   Huang, Yi ^a   Wang, Yun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Myasthenia gravis; Toll like receptors; Urymus

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART SURGERY; HUMAN; HUMAN TISSUE; MYASTHENIA GRAVIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMECTOMY; THYMOMA; THYMUS;

ADOLESCENT; ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMUS GLAND; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 46749118431     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol, 2002,2:797-804.
2. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol, 2001,2:675-680.
3. Klinman D. Does activation of the innate immune system contribute to the development of rheumatoid arthritis? Arthritis Rheum, 2003,48:590-593.
4. Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature, 2002,416:603-607.
5. Bsibsi M, Ravid R, Gveric D, et al. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol, 2002,61:1013-1021.
6. Marx A, Wilisch A, Schultz A, et al. Pathogenesis of myasthenia gravis. Virchows Arch, 1997,430:355-364.
7. Kelly D, Conway S. Bacterial modulation of mucosal innate immunity. Mol Immunol, 2005,42:895-901.
8. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/ toll-like receptor superfamily. Curr Top Microbiol Immunol, 2002,270:47-61.
9. Nagata T, Onodera H, Ohuchi M, et al. Decreased expression of c-myc family genes in thymuses from myasthenia gravis patients. J Neuroimmunol, 2001,115:199-202.
10. Wang ZY, He B, Qiao J, et al. Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral ad-ministration of acetylcholine receptor and myelin basic protein: double tolerance. J Neuroimmunol, 1995,63:79-86.
11. Sassano P, Paparo F, Ramieri V, et al. Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland. Med Hypotheses, 2007,68:314-317.
12. Bhibhatbhan A, Kline G, Vincent A, et al. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus. Muscle Nerve, 2007,36:264-266.
13. Nakamura K, Deyama Y, Yoshimura Y, et al. Toll-like receptor 3 ligand-induced antiviral response in mouse osteoblastic cells. Int J Mol Med, 2007,19:771-775.
14. Wilisch A, Gutsche S, Hoffacker V, et al. Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis. Neurology, 1999,52:1460-1466.
15. Kuzmenok OI, Dvoryanchikov GA, Ponomareva EN, et al. Myasthenia gravis accompanied by thymomas not related to foamy virus genome in Belarusian's patients. Int J Neurosci, 2007,117:1603-1610.